Moffitt Cancer Center study finds "overmanagement" of benign breast disease
- Posted: May 3, 2012
Contrary to current guidelines, women with benign breast biopsies do not need follow-up at six months; they may not need close surveillance at all, a new study shows. The study, conducted at Moffitt Cancer Center in Tampa, Fla., followed 388 patients for six, 12 and 24 months. No cancer was found in these patients at six and 12 months. An annual mammogram, as part of regular preventive care, could replace the need for benign breast disease follow-up of these patients.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.